If you have type 2 diabetes you are in danger of developing chronic kidney disease (CKD). A number of medications are available for controlling diabetes but not many of them are safe for use with CKD, and where they are used they may require an adjusted dosage. But recently researchers have found that metformin can be safely used to lower HbA1c regardless of stage 3 CKD status.
In a study published in the journal Diabetes, Obesity, and Metabolism, it was stated that metformin had the same efficacy in lowering blood sugar in patients with and without CKD3. Therefore, metformin is a valuable option for newly treated patients with T2D and CKD3.
Another study stated that the use of metformin and other glucose-lowering drugs has increased significantly for patients with chronic kidney disease (CKD) and type 2 diabetes. The report published in Healio went on to state that for “patients at CKD stage 3 or higher (eGFR 30 mL/min/1.73 m2), metformin is the recommended first-line treatment choice because of its safety, low cost, and potential cardiovascular benefits.”
Metformin has long been the treatment of choice for patients with type 2 diabetes, but hearing that it’s also effective in treating patients with chronic kidney disease stage 3 can bring some measure of hope to those patients.
For more articles like this and other updates, please fill in the form below.